17.14
前日終値:
$17.25
開ける:
$17.28
24時間の取引高:
159.24K
Relative Volume:
1.02
時価総額:
$1.05B
収益:
-
当期純損益:
$-46.13M
株価収益率:
-21.10
EPS:
-0.8123
ネットキャッシュフロー:
$-34.10M
1週間 パフォーマンス:
-3.55%
1か月 パフォーマンス:
-20.79%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+60.49%
Pulse Biosciences Inc Stock (PLSE) Company Profile
PLSE を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
PLSE
Pulse Biosciences Inc
|
17.14 | 1.05B | 0 | -46.13M | -34.10M | -0.8123 |
![]()
ISRG
Intuitive Surgical Inc
|
493.72 | 176.09B | 8.35B | 2.32B | 1.30B | 6.41 |
![]()
BDX
Becton Dickinson Co
|
224.92 | 64.58B | 20.64B | 1.73B | 2.94B | 6.02 |
![]()
ALC
Alcon Inc
|
89.15 | 44.10B | 9.91B | 1.02B | 665.00M | 2.05 |
![]()
RMD
Resmed Inc
|
225.79 | 33.17B | 4.93B | 1.25B | 1.38B | 8.47 |
![]()
BAX
Baxter International Inc
|
35.85 | 18.30B | 17.28B | 108.00M | 391.00M | 0.20 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2021-07-27 | 開始されました | Stephens | Overweight |
2021-03-11 | 開始されました | Maxim Group | Buy |
2021-01-26 | 繰り返されました | H.C. Wainwright | Buy |
2020-05-12 | アップグレード | H.C. Wainwright | Neutral → Buy |
2020-02-14 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2019-02-25 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Pulse Biosciences Inc (PLSE) 最新ニュース
Oppenheimer & Co. Inc. Acquires New Shares in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025 - Bluefield Daily Telegraph
When Will Pulse Biosciences Report Q4 Earnings? Key Date for nsPFA Technology Leader - StockTitan
Pulse Biosciences, Inc. to Host Earnings Call - ACCESS Newswire
Pulse Biosciences at TD Cowen Conference: nsPFA Technology Focus By Investing.com - Investing.com Canada
New York State Common Retirement Fund Sells 3,600 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
(PLSE) Trading Signals - Stock Traders Daily
Commit To Purchase Pulse Biosciences At $10, Earn 12.9% Annualized Using Options - Nasdaq
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Joplin Globe
Is Pulse Biosciences' Hiring Spree a Signal for Investors? 165,300 New Stock Options Granted - StockTitan
MONDAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm - ACCESS Newswire
Investor Network: Pulse Biosciences, Inc. to Host Earnings Call - ACCESS Newswire
Jon Skinner Hired to Manage Pulse Biosciences Finances - MPO-mag
Pulse Biosciences Releases Nanosecond PFA Catheter Study Results - MPO-mag
Learn to Evaluate (PLSE) using the Charts - Stock Traders Daily
Pulse Biosciences (NASDAQ:PLSE) Trading Down 7.8%Here's Why - MarketBeat
Can Pulse Biosciences' Novel Ablation Technology Disrupt Medical Device Market? Key Presentation Coming - StockTitan
Where are the Opportunities in (PLSE) - Stock Traders Daily
Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 6.6%Here's What Happened - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Hits New 12-Month HighShould You Buy? - MarketBeat
Pulse Biosciences Appoints Jon Skinner as Chief Financial Officer - Defense World
Pulse Biosciences names new CFO, continuing string of C-suite changes - MedTech Dive
Pulse Biosciences names Jon Skinner as new CFO By Investing.com - Investing.com South Africa
Pulse Biosciences names Jon Skinner as new CFO - Investing.com India
Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer - BioSpace
Pulse Biosciences has a new CFO - Mass Device
Pulse Biosciences Strengthens Leadership with New CFO Appointment - TipRanks
Pulse Biosciences Names Jon Skinner CFO -February 04, 2025 at 08:54 am EST - Marketscreener.com
Pulse Biosciences Appoints Jon Skinner As CFO; Stock Up In Pre-market - Nasdaq
Pulse Biosciences Names Jon Skinner Chief Financial Officer - MarketWatch
Healthcare M&A Expert Takes CFO Role at Pulse Biosciences with $5B Growth Vision - StockTitan
Pulse Biosciences (NASDAQ:PLSE) Trading Up 7.6%Time to Buy? - MarketBeat
Griffin Asset Management Inc. Sells 19,902 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - MarketBeat
(PLSE) Technical Pivots with Risk Controls - Stock Traders Daily
Pulse Biosciences’ Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting - BioSpace
Pulse Biosciences reports successful AF treatment in study - MSN
Pulse Biosciences announces presentation of late-breaking data on nsPFA 360-degree cardiac catheter system - Cardiac Rhythm News
Pulse Biosciences (NASDAQ:PLSE) Shares Up 5.2%Here's What Happened - MarketBeat
Pulse Biosciences touts positive results from PFA early feasibility study - Yahoo Finance
Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium - Business Wire
Barclays PLC Grows Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Purchased by Barclays PLC - MarketBeat
Pulse Biosciences Inc (PLSE) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):